Carclo plc

12/16/2024 | Press release | Archived content

Drug Delivery to the Lungs 2024

We are excited to share our recent participation in DDL 2024. It was an enriching experience that provided us with invaluable insights and connections.

We would like to extend our heartfelt thanks to the organizers for their outstanding effort in bringing this event to life. The seamless organization truly made a difference. A special shout-out goes to the speakers, whose expertise and knowledge inspired us all.

Participating in DDL 2024 not only brought value to our team but, more importantly, it will allow us to better serve our customers. The insights gained and the relationships built during this event equip us to enhance our offerings and drive innovation tailored to their needs.

Additionally, we greatly appreciate the opportunity to connect with fellow exhibitors and attendees. The new contacts we've made during this event are essential for us as we strive to build and nurture strong relationships in our industry.

We look forward to leveraging these connections as we move forward and to participating in future events that continue to foster collaboration and innovation.

Thank you once again to everyone involved in DDL 2024!

Team Carclo
Carclo plc published this content on December 16, 2024, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on July 15, 2025 at 13:33 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]